KIR2DL3
Killer cell immunoglobulin-like receptor 2DL3
Protein Summary
Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis. Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif ...more
- ENST00000342376
- ENSP00000342215
- ENSG00000243772
- ENST00000610407
- ENSP00000478848
- ENSG00000274830
- ENST00000611207
- ENSP00000478657
- ENSG00000276218
- ENST00000611369
- ENSP00000483975
- ENSG00000277484
- ENST00000611821
- ENSP00000484459
- ENSG00000276590
- ENST00000611990
- ENSP00000479121
- ENSG00000278327
- ENST00000614792
- ENSP00000481237
- ENSG00000277554
- ENST00000615091
- ENSP00000483551
- ENSG00000275658
- ENST00000615739
- ENSP00000478136
- ENSG00000273887
- ENST00000617150
- ENSP00000481159
- ENSG00000274952
- ENST00000617242
- ENSP00000483883
- ENSG00000274410
- ENST00000617404
- ENSP00000481478
- ENSG00000275008
- ENST00000617593
- ENSP00000483192
- ENSG00000274108
- ENST00000617790
- ENSP00000481355
- ENSG00000275623
- ENST00000619702
- ENSP00000480464
- ENSG00000274402
- ENST00000619995
- ENSP00000480087
- ENSG00000277317
- ENST00000620549
- ENSP00000483419
- ENSG00000277924
- ENST00000622644
- ENSP00000482830
- ENSG00000276459
- ENST00000638813
- ENSP00000492856
- ENSG00000284333
- ENST00000638851
- ENSP00000491452
- ENSG00000283708
- ENST00000639089
- ENSP00000491264
- ENSG00000283702
- ENST00000639101
- ENSP00000492356
- ENSG00000283790
- ENST00000639176
- ENSP00000491273
- ENSG00000284504
- ENST00000640485
- ENSP00000491955
- ENSG00000284510
- CD158B2
- KIRCL23
- NKAT2
- p58
- NKAT
- GL183
- NKAT2
- CD158b
- KIR2DL
- NKAT2A
- NKAT2B
- CD158B2
- KIR-K7b
- KIR-K7c
- KIR2DS5
- KIRCL23
- KIR-023GB
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
phenotype | 1 | ||
disease | 0.75 | ||
biological term | 0.64 | ||
cell line | 0.64 | ||
tissue | 0.61 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 465.89 (req: < 5)
Gene RIFs: 71 (req: <= 3)
Antibodies: 499 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 465.89 (req: >= 5)
Gene RIFs: 71 (req: > 3)
Antibodies: 499 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0